{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:58:17Z","timestamp":1791475097767,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100737"],"award-info":[{"award-number":["82100737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2022CR80"],"award-info":[{"award-number":["2022CR80"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2022CX15"],"award-info":[{"award-number":["2022CX15"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2511004"],"award-info":[{"award-number":["2024YFC2511004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2511000"],"award-info":[{"award-number":["2024YFC2511000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015629","name":"Chinook Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-046"],"award-info":[{"award-number":["2019-I2M-5-046"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xkme.2025.101104","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:29:34Z","timestamp":1758079774000},"page":"101104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Relapse and Long-Term Kidney Outcomes in IgA Nephropathy"],"prefix":"10.1016","volume":"7","author":[{"given":"Xue","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.xkme.2025.101104_bib1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.V82199","article-title":"Predicting renal outcome in IgA nephropathy","volume":"8","author":"Radford","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101104_bib3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.2018101017","article-title":"Mortality in IgA nephropathy: a nationwide population-based cohort study","volume":"30","author":"Jarrick","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.xkme.2025.101104_bib4","doi-asserted-by":"crossref","first-page":"ii40","DOI":"10.1093\/ckj\/sfad224","article-title":"Systemic and targeted steroids for the treatment of IgA nephropathy","volume":"16","author":"Locatelli","year":"2023","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2025.101104_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","article-title":"IgA nephropathy: core curriculum 2021","volume":"78","author":"Pattrapornpisut","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.xkme.2025.101104_bib7","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101104_bib8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ki.2015.241","article-title":"Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis","volume":"88","author":"Barbour","year":"2015","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2025.101104_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.ajkd.2023.12.016","article-title":"Time-varying proteinuria and progression of IgA nephropathy: a cohort study","volume":"84","author":"Tang","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/0886022X.2015.1128251","article-title":"The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial","volume":"38","author":"Yang","year":"2016","journal-title":"Ren Fail"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib12","first-page":"CD003962","article-title":"Non-immunosuppressive treatment for IgA nephropathy","volume":"2","author":"Tunnicliffe","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.xkme.2025.101104_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5414\/CN107861","article-title":"Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients","volume":"80","author":"Ohya","year":"2013","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2025.101104_bib14","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1007\/s00467-023-05919-9","article-title":"Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial","volume":"38","author":"Zhang","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54054","article-title":"Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy: a randomized clinical trial","volume":"6","author":"Hou","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cei.13530","article-title":"Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns","volume":"203","author":"Oristrell","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101104_bib17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/rheumatology\/keaa599","article-title":"Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis","volume":"60","author":"Okamoto","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.xkme.2025.101104_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1277017","article-title":"Risk factors and outcomes of IgA nephropathy recurrence after kidney transplantation: a systematic review and meta-analysis","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.xkme.2025.101104_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10157-022-02221-0","article-title":"The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy","volume":"26","author":"Tsushima","year":"2022","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00467-023-06116-4","article-title":"Factors related to recurrence of proteinuria in childhood IgA nephropathy","volume":"39","author":"Shima","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2025.101104_bib21","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2025.101104_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.xkme.2025.101104_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137870","article-title":"Association of relapse with renal outcomes under the current therapy regimen for IgA nephropathy: a multi-center study","volume":"10","author":"Yuan","year":"2015","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1681\/ASN.2020030349","article-title":"Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy","volume":"32","author":"Canney","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101104_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2010.466","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies","volume":"79","author":"Hill","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.xkme.2025.101104_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","article-title":"Evaluating a new international risk-prediction tool in IgA nephropathy","volume":"179","author":"Barbour","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.xkme.2025.101104_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.kint.2022.02.042","article-title":"Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy","volume":"102","author":"Barbour","year":"2022","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2025.101104_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.kint.2020.07.046","article-title":"Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy","volume":"99","author":"Schena","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2025.101104_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2215\/CJN.08600718","article-title":"Proteinuria reduction as a surrogate end point in trials of IgA nephropathy","volume":"14","author":"Thompson","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101104_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ajkd.2016.02.042","article-title":"Early change in urine protein as a surrogate end point in studies of IgA nephropathy: an individual-patient meta-analysis","volume":"68","author":"Inker","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2025.101104_bib31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","article-title":"Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population","volume":"27","author":"Le","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2025.101104_bib32","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.63","article-title":"Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments","volume":"86","author":"Coppo","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2025.101104_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ndt\/gfae085","article-title":"Albuminuria predicts kidney events in IgA nephropathy","volume":"40","author":"Faucon","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2025.101104_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ndt\/gfae252","article-title":"Long-term outcomes of IgA nephropathy in China","volume":"40","author":"Shen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2025.101104_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.xkme.2025.101104_bib37","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2022.5368","article-title":"Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"327","author":"Lv","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.xkme.2025.101104_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12882-019-1519-3","article-title":"Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101104_bib41","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1159\/000496000","article-title":"Efficacy and safety of agents in IgA nephropathy: an update network meta-analysis","volume":"43","author":"Yang","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"10.1016\/j.xkme.2025.101104_bib42","first-page":"CD003965","article-title":"Immunosuppressive agents for treating IgA nephropathy","author":"Samuels","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1016\/j.xkme.2025.101104_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nep.14369","article-title":"Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials","volume":"29","author":"Chen","year":"2024","journal-title":"Nephrol (Carlton)"},{"issue":"6","key":"10.1016\/j.xkme.2025.101104_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ki.2009.499","article-title":"Long-term study of mycophenolate mofetil treatment in IgA nephropathy","volume":"77","author":"Tang","year":"2010","journal-title":"Kidney Int"},{"issue":"10405","key":"10.1016\/j.xkme.2025.101104_bib45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.xkme.2025.101104_bib46","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.34067\/KID.0002972021","article-title":"The phenotypic difference of IgA nephropathy and its race\/gender-dependent molecular mechanisms","volume":"2","author":"Suzuki","year":"2021","journal-title":"Kidney360"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:05:51Z","timestamp":1773219951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2590059525001402"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101104","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Relapse and Long-Term Kidney Outcomes in IgA Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101104"}}